Page last updated: 2024-08-18

4-butyrolactone and Mesothelioma

4-butyrolactone has been researched along with Mesothelioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gabrielson, EW; Kuhajda, FP; Pinn, ML; Testa, JR	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Mesothelioma

Article	Year
Increased fatty acid synthase is a therapeutic target in mesothelioma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:1 Topics: 4-Butyrolactone; Animals; Antifungal Agents; Antineoplastic Agents; Cerulenin; Disease Models, Animal; Fatty Acid Synthases; Humans; Immunoenzyme Techniques; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Mesothelial; Paraffin Embedding; Prognosis; Tumor Cells, Cultured	2001

Article

Year

Increased fatty acid synthase is a therapeutic target in mesothelioma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:1

Topics: 4-Butyrolactone; Animals; Antifungal Agents; Antineoplastic Agents; Cerulenin; Disease Models, Animal; Fatty Acid Synthases; Humans; Immunoenzyme Techniques; Mesothelioma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Mesothelial; Paraffin Embedding; Prognosis; Tumor Cells, Cultured

2001